Jürgen Floege
#107,026
Most Influential Person Now
Jürgen Floege's AcademicInfluence.com Rankings
Jürgen Floegemedical Degrees
Medical
#1361
World Rank
#1689
Historical Rank
Nephrology
#3
World Rank
#3
Historical Rank

Download Badge
Medical
Why Is Jürgen Floege Influential?
(Suggest an Edit or Addition)Jürgen Floege's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis (2012) (1147)
- The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. (2003) (933)
- Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study (2003) (911)
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (2012) (885)
- Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. (2012) (795)
- Renal injury from angiotensin II-mediated hypertension. (1992) (555)
- Renal fibrosis: novel insights into mechanisms and therapeutic targets (2010) (521)
- The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. (2011) (511)
- Recruitment of podocytes from glomerular parietal epithelial cells. (2009) (436)
- Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. (1992) (430)
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens (2014) (430)
- Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population (2010) (417)
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. (2021) (414)
- Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor (1992) (359)
- Cellular events in the evolution of experimental diabetic nephropathy. (1995) (334)
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial (2017) (317)
- Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. (2006) (312)
- Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis (2012) (302)
- A new look at platelet-derived growth factor in renal disease. (2008) (293)
- Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. (1996) (280)
- Increased synthesis of extracellular matrix in mesangial proliferative nephritis. (1991) (276)
- Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. (2007) (266)
- Genetic loci influencing kidney function and chronic kidney disease (2010) (266)
- Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. (1993) (260)
- Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. (2012) (259)
- Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. (2004) (259)
- Nanoparticle-based test measures overall propensity for calcification in serum. (2012) (249)
- Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. (1999) (241)
- Decoding myofibroblast origins in human kidney fibrosis (2020) (236)
- Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. (2005) (229)
- Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. (2009) (223)
- Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. (2011) (213)
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial (2017) (213)
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (2015) (212)
- The activated mesangial cell: a glomerular "myofibroblast"? (1992) (206)
- Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. (1992) (203)
- Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. (2009) (200)
- Vascular calcification in chronic kidney disease: an update. (2016) (197)
- IgA nephropathy: recent developments. (2000) (196)
- Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. (2011) (191)
- Vascular calcification in patients with end-stage renal disease. (2004) (187)
- Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration (2013) (185)
- Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. (1994) (180)
- Pro-fibrogenic potential of PDGF-D in liver fibrosis. (2007) (180)
- Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (179)
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. (2015) (178)
- Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. (1993) (171)
- Fetuin-A protects against atherosclerotic calcification in CKD. (2009) (169)
- Ultrastructural analysis of vascular calcifications in uremia. (2010) (165)
- Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. (2007) (161)
- Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. (2015) (161)
- Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. (1993) (159)
- A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients (2014) (159)
- Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. (1995) (157)
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. (2021) (149)
- Cardiovascular Disease in Chronic Kidney Disease (2021) (147)
- Primary glomerulonephritides (2016) (146)
- Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. (1988) (145)
- l-Carnosine, a Substrate of Carnosinase-1, Influences Glucose Metabolism (2007) (142)
- Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. (1992) (142)
- Treatment targets in renal fibrosis. (2007) (141)
- Origin of regenerating tubular cells after acute kidney injury (2014) (140)
- Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD. (2017) (139)
- European consensus statement on the terminology used in the management of lupus glomerulonephritis (2009) (137)
- The Montreal Cognitive Assessment (MoCA) - A Sensitive Screening Instrument for Detecting Cognitive Impairment in Chronic Hemodialysis Patients (2014) (136)
- Development and validation of a predictive mortality risk score from a European hemodialysis cohort (2015) (135)
- Use of phosphate-binding agents is associated with a lower risk of mortality. (2013) (135)
- Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. (2001) (133)
- Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. (2015) (131)
- Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. (2014) (131)
- Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon (2006) (131)
- β2-microglobulin associated amyloidosis: A vanishing complication of long-term hemodialysis? (1997) (131)
- Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. (1997) (130)
- Beta-2-microglobulin-associated amyloidosis. (1996) (130)
- Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. (2008) (129)
- Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. (2003) (126)
- Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. (1997) (124)
- Role of platelet-derived growth factor in glomerular disease. (1993) (123)
- The German Chronic Kidney Disease (GCKD) study: design and methods. (2012) (123)
- Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. (2015) (122)
- Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. (1991) (120)
- Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry (2016) (120)
- Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients (2015) (120)
- High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. (2015) (119)
- Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. (2006) (118)
- WNT–β-catenin signalling — a versatile player in kidney injury and repair (2020) (115)
- PDGF in organ fibrosis. (2017) (114)
- Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (113)
- Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial (2014) (112)
- Calcification Propensity and Survival among Renal Transplant Recipients. (2016) (110)
- Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. (1993) (110)
- Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. (2000) (109)
- Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. (1992) (109)
- Albumin is recycled from the primary urine by tubular transcytosis. (2013) (108)
- Complement C5 mediates experimental tubulointerstitial fibrosis. (2007) (108)
- Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. (2017) (105)
- PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. (2008) (104)
- Sodium thiosulfate in the treatment of calcific uremic arteriolopathy (2009) (104)
- Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study. (2017) (103)
- GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials. (2019) (103)
- A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. (2003) (102)
- Quantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney Diseases. (2016) (101)
- Treatment of Renal Fibrosis-Turning Challenges into Opportunities. (2017) (100)
- The mucosa–kidney axis in IgA nephropathy (2016) (100)
- Adynamic bone disease—bone and beyond (2008) (100)
- β2-Microglobulin–derived amyloidosis: An update (2001) (99)
- Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. (1997) (98)
- Recurrent IgA nephropathy after renal transplantation. (2004) (98)
- Relation of circulating matrix Gla-protein and anticoagulation status in patients with aortic valve calcification (2009) (97)
- The regenerative potential of parietal epithelial cells in adult mice. (2014) (97)
- Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury (2008) (97)
- High cardiovascular event rates occur within the first weeks of starting hemodialysis (2015) (97)
- Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? (2009) (97)
- Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. (2007) (95)
- The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. (2015) (95)
- Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. (2012) (95)
- The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? (2011) (93)
- Warfarin Induces Cardiovascular Damage in Mice (2013) (93)
- Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. (2006) (93)
- The renal (myo-)fibroblast: a heterogeneous group of cells. (2012) (91)
- Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD. (2014) (91)
- Chronic kidney disease growth factors in renal fibrosis (2011) (90)
- Current therapy for IgA nephropathy. (2011) (90)
- GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway (2016) (89)
- Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients. (2016) (89)
- Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus. (2001) (86)
- Rodent models of nephropathy associated with type II diabetes. (1999) (86)
- The PDGF family in renal fibrosis (2012) (86)
- Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. (2003) (86)
- Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. (2010) (85)
- Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. (1995) (84)
- Role of contact system activation in hemodialyzer-induced thrombogenicity. (2001) (84)
- Multiple roles for platelet-derived growth factor in renal disease. (1995) (84)
- Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects. (1991) (83)
- High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. (1989) (82)
- Treatment of IgA nephropathy and Henoch–Schönlein nephritis (2013) (82)
- Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC) (2005) (82)
- Notch‐3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury (2012) (82)
- SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (2021) (82)
- Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. (2008) (81)
- Y-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ Effects* (2006) (81)
- Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. (1994) (81)
- PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. (2003) (81)
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. (2010) (81)
- COSMOS: the dialysis scenario of CKD-MBD in Europe. (2013) (80)
- Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease. (2011) (79)
- PDGF and the progression of renal disease. (2014) (79)
- Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. (2013) (79)
- Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. (2014) (79)
- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. (2019) (78)
- Vascular access calcification predicts mortality in hemodialysis patients. (2008) (77)
- Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. (2003) (77)
- Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. (2014) (76)
- Renal Allograft Fibrosis: Biology and Therapeutic Targets (2015) (76)
- The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (2015) (75)
- Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. (2014) (74)
- Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. (2002) (70)
- Mesangial cells in the pathogenesis of progressive glomerular disease in animal models (1992) (70)
- Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. (2006) (70)
- Keratins are novel markers of renal epithelial cell injury. (2016) (70)
- Cardiac Remodeling in Chronic Kidney Disease (2020) (69)
- In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. (2002) (69)
- Recurrent glomerulonephritis following renal transplantation: an update. (2003) (68)
- Role of T cells and dendritic cells in glomerular immunopathology (2007) (68)
- Podocyte Damage Resulting in Podocyturia: A Potential Diagnostic Marker to Assess Glomerular Disease Activity (2007) (67)
- The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. (2013) (65)
- Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients. (2009) (64)
- Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. (2011) (62)
- After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. (2020) (61)
- Association of SGK1 Gene Polymorphisms with Type 2 Diabetes (2008) (60)
- Novel Insights into Uremic Vascular Calcification: Role of Matrix Gla Protein and Alpha-2-Heremans Schmid Glycoprotein/Fetuin (2002) (60)
- Platelet-derived growth factor: a potentially important cytokine in glomerular disease. (1992) (60)
- PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. (2007) (59)
- Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis. (2015) (59)
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE (2015) (59)
- Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin. (1990) (58)
- Subtotal ablation of parietal epithelial cells induces crescent formation. (2012) (58)
- Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss. (2018) (58)
- beta2-microglobulin-derived amyloidosis: an update. (2001) (57)
- Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study. (2013) (57)
- Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy. (2017) (56)
- YB-1 Is an Early and Central Mediator of Bacterial and Sterile Inflammation In Vivo (2013) (56)
- Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. (1997) (56)
- Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC). (2005) (56)
- Primary Cultures of Glomerular Parietal Epithelial Cells or Podocytes with Proven Origin (2012) (55)
- Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. (2013) (55)
- Exposure to Uremic Serum Induces a Procalcific Phenotype in Human Mesenchymal Stem Cells (2011) (55)
- Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. (1989) (54)
- Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases. (2015) (54)
- Deep Learning-Based Segmentation and Quantification in Experimental Kidney Histopathology. (2020) (54)
- Effects of rhGH and rhIGF-1 on renal growth and morphology. (1993) (53)
- Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. (2014) (53)
- Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. (2006) (53)
- Modulation of experimental mesangial proliferative nephritis by interferon-gamma. (1995) (53)
- Electrical forces determine glomerular permeability. (2010) (53)
- Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. (2013) (53)
- Phosphate binders in chronic kidney disease: a systematic review of recent data (2016) (53)
- The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. (2002) (53)
- Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. (2012) (53)
- Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis (2019) (53)
- Big science and big data in nephrology. (2019) (52)
- Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis (2003) (52)
- Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. (1998) (52)
- Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. (1992) (51)
- Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. (2009) (51)
- Glomerular cells in vitro versus the glomerulus in vivo. (1994) (51)
- Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest. (2017) (50)
- Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. (2005) (49)
- CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. (2008) (49)
- Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
- Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time? (2009) (49)
- Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. (2011) (49)
- Progression of Diabetic Nephropathy (1999) (48)
- Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers. (2020) (48)
- Role of interferon-γ gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study (2006) (48)
- Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells. (2006) (47)
- Improving hand hygiene compliance rates in the haemodialysis setting: more than just more hand rubs. (2012) (47)
- Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? (2016) (47)
- Recurrent IgA nephropathy after kidney transplantation: not a benign condition. (1998) (47)
- Localization of PDGF α-receptor in the developing and mature human kidney (1997) (47)
- Development and validation of cardiovascular risk scores for haemodialysis patients. (2016) (46)
- Endogenous fibroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. (1998) (46)
- Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis (2014) (45)
- Investigations of Glucocorticoid Action in GN. (2017) (45)
- When man turns to stone: extraosseous calcification in uremic patients. (2004) (45)
- Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? (1997) (44)
- Extracellular YB-1 Blockade in Experimental Nephritis Upregulates Notch-3 Receptor Expression and Signaling (2011) (44)
- The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat. (2004) (44)
- Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy. (2016) (44)
- Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial. (2016) (44)
- Steroid-related osteonecrosis--an update. (2011) (44)
- Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. (2010) (43)
- PDGF-C mediates glomerular capillary repair. (2010) (43)
- Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy (2020) (43)
- Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney. (1999) (43)
- Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide (2016) (43)
- Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients. (2013) (43)
- Activation of the acute phase response and complement C3 in patients with IgA nephropathy. (2000) (43)
- Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis. (2002) (42)
- Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? (1994) (42)
- IL-6 Trans-Signaling Drives Murine Crescentic GN. (2016) (42)
- Biocompatibility of Peritoneal Dialysis Fluids: Long-term Exposure of Nonuremic Rats (2004) (42)
- Risk Factors for Cardiovascular Calcifications in Non-Diabetic Caucasian Haemodialysis Patients (2009) (42)
- Y-Box Binding Protein-1 Mediates Profibrotic Effects of Calcineurin Inhibitors in the Kidney (2011) (42)
- Diffusion‐weighted MRI does not reflect kidney fibrosis in a rat model of fibrosis (2015) (42)
- Origin of parietal podocytes in atubular glomeruli mapped by lineage tracing. (2014) (42)
- Urinary Exosomes: A Novel Means to Non-Invasively Assess Changes in Renal Gene and Protein Expression (2014) (41)
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. (2016) (41)
- Dialysis related amyloidosis: a disease of chronic retention and inflammation? (1992) (41)
- Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. (2009) (41)
- Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases (2021) (40)
- Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse. (2005) (39)
- Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions (2019) (39)
- Early experience with COVID-19 in kidney transplantation (2020) (39)
- New insights into the pathogenesis of IgA nephropathy (2014) (38)
- Magnesium in CKD: more than a calcification inhibitor? (2014) (38)
- cAMP-responsive Element Modulator α (CREMα) Contributes to Decreased Notch-1 Expression in T Cells from Patients with Active Systemic Lupus Erythematosus (SLE)* (2012) (38)
- Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis. (2017) (38)
- The Genetic Evolution of Melanoma (2016) (37)
- The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy. (2005) (37)
- Progression of renal failure: what is the role of cytokines? (1995) (37)
- Lumbar bone mineral density in very long-term renal transplant recipients: Impact of circulating sex hormones (2005) (37)
- Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits. (2006) (37)
- “Missing” inhibitors of calcification: general aspects and implications in renal failure (2005) (37)
- The role of PDGF-D in healthy and fibrotic kidneys. (2016) (36)
- Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys. (2020) (36)
- Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. (2018) (36)
- Novel insights into renal fibrosis (2003) (35)
- Prognostic impact of renal arterial resistance index upon renal allograft survival: the time point matters. (2012) (35)
- Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. (2008) (34)
- Analysis of calcifications in patients with coral reef aorta. (2010) (34)
- The vulnerable patient with chronic kidney disease. (2016) (34)
- R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury. (2005) (33)
- Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy. (2020) (33)
- No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. (2008) (33)
- Evidence-based recommendations for immunosuppression in IgA nephropathy: handle with caution. (2003) (33)
- Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells. (2002) (32)
- Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. (2022) (32)
- Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid. (1998) (32)
- Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes. (1999) (32)
- Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them? (2008) (32)
- Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. (2005) (31)
- Specific imaging of dialysis-related amyloid deposits using 131I-beta-2-microglobulin. (1989) (31)
- Inhibition of the renin-angiotensin system ameliorates genetically determined hyperinsulinemia. (2002) (31)
- Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24. (2009) (31)
- Inflammation in IgA nephropathy (2017) (31)
- Management of hyperphosphataemia in chronic kidney disease—challenges and solutions (2013) (30)
- Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis. (2016) (30)
- Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients (2018) (30)
- Calcineurin-mediated YB-1 Dephosphorylation Regulates CCL5 Expression during Monocyte Differentiation* (2014) (30)
- Differential activation of memory-relevant brain regions during a dialysis cycle. (2010) (30)
- Differentially Spliced Isoforms of FAT1 Are Asymmetrically Distributed within Migrating Cells* (2007) (30)
- Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. (2019) (29)
- IgA nephropathy: new insights into the role of complement. (2018) (29)
- Subcutaneous amyloid-tumor of beta-2-microglobulin origin in a long-term hemodialysis patient. (1989) (29)
- Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). (2008) (29)
- Novel 3D analysis using optical tissue clearing documents the evolution of murine rapidly progressive glomerulonephritis. (2019) (29)
- Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function (2017) (29)
- Recurrent IgA nephropathy in the renal allograft: not a benign condition. (2013) (29)
- Henoch-Schönlein purpura complicated by cardiac involvement: case report and review of the literature. (2009) (28)
- Patients with IgA nephropathy exhibit high systemic PDGF-DD levels. (2009) (28)
- Tacrolimus- (FK 506) based immunosuppression in severe systemic lupus erythematosus. (2004) (28)
- Current treatment of IgA nephropathy (2021) (27)
- Vitamin K Antagonists: Beyond Bleeding (2014) (27)
- MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application (2020) (27)
- Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors. (2004) (27)
- Growth arrest-specific protein 1 is a novel endogenous inhibitor of glomerular cell activation and proliferation. (2013) (26)
- FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients (2016) (26)
- A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects. (2012) (26)
- Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis. (2004) (26)
- Osteogenesis of Heterotopically Transplanted Mesenchymal Stromal Cells in Rat Models of Chronic Kidney Disease (2013) (26)
- An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study (2010) (26)
- Medical options to fight mortality in end-stage renal disease: a review of the literature. (2012) (26)
- Sodium thiosulphate and progression of vascular calcification in end-stage renal disease patients: a double-blind, randomized, placebo-controlled study. (2019) (26)
- A collagen-binding protein enables molecular imaging of kidney fibrosis in vivo. (2019) (25)
- Key metalloproteinase-mediated pathways in the kidney (2021) (25)
- Release, Upregulated Synthesis, and Mitogenicity in Mesangial Proliferative Glomerulonephritis (1992) (25)
- CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC (2012) (25)
- A Novel Bioimpedance Technique to Monitor Fluid Volume State During Hemodialysis Treatment (2010) (25)
- Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease (2018) (25)
- Urinary IgA, secretory IgA and secretory component in women with recurrent urinary tract infections. (1990) (25)
- Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort (2016) (24)
- Localization of PDGF alpha-receptor in the developing and mature human kidney. (1997) (24)
- CHAPTER 15 – Introduction to Glomerular Disease: Clinical Presentations (2010) (24)
- Phosphate binders in chronic kidney disease: an updated narrative review of recent data (2019) (24)
- Clinical research for patient empowerment--a qualitative approach on the improvement of heart health promotion in chronic illness. (2008) (23)
- Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts. (2013) (23)
- Why Target the Gut to Treat IgA Nephropathy? (2020) (23)
- Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis. (2011) (23)
- The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait (2005) (23)
- Platelet Hyperaggregability is Highly Prevalent in Patients With Chronic Kidney Disease (2015) (23)
- Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation (2018) (23)
- The platelet-derived growth factor system in renal disease: an emerging role of endogenous inhibitors. (2012) (23)
- Present and future therapy options in IgA-nephropathy. (2005) (23)
- Association Between Dietary Patterns and Kidney Function in Patients With Chronic Kidney Disease: A Cross-Sectional Analysis of the German Chronic Kidney Disease Study. (2019) (23)
- YB‐1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation (2017) (22)
- Immune modulating therapy for IgA nephropathy: rationale and evidence. (2008) (22)
- Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis (2020) (22)
- No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. (2004) (22)
- Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores) (2018) (21)
- CHAPTER 22 – IgA Nephropathy and Henoch-Schönlein Nephritis (2010) (21)
- Cytokines in renal inflammation (1993) (21)
- Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. (2022) (20)
- Gas6 protein: its role in cardiovascular calcification (2016) (20)
- Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. (2016) (20)
- Nephrology research—the past, present and future (2015) (20)
- Kidney calling lung and call back: how organs talk to each other. (2010) (20)
- SGLT-2 inhibition in IgA nephropathy: the new standard-of-care? (2021) (20)
- Complement C5a receptors C5L2 and C5aR in renal fibrosis. (2018) (19)
- Renal side effects of anti-VEGF therapy in man: a new test system. (2007) (19)
- Conversion of Goodpasture's syndrome into membranous glomerulonephritis. (2001) (19)
- Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes. (2006) (19)
- Cold shock protein YB-1 is involved in hypoxia-dependent gene transcription. (2016) (19)
- Hemodialysis-Related Induction of β2-Microglobulin Synthesis and Release by Mononuclear Phagocytes (1990) (19)
- One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis (2017) (19)
- High-fat diet-induced obesity causes an inflammatory microenvironment in the kidneys of aging Long-Evans rats (2019) (19)
- Sclerostin deficiency modifies the development of CKD-MBD in mice. (2018) (19)
- Recombinant versus natural human 111In-β2-microglobulin for scintigraphic detection of Aβ2m amyloid in dialysis patients (2000) (18)
- Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic (2011) (18)
- Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy? (2010) (18)
- Is the rise in plasma beta-2-microglobulin seen during hemodialysis meaningful? (1989) (18)
- Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. (2019) (18)
- Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial (2016) (18)
- Gp130-dependent signaling in the podocyte. (2014) (17)
- Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. (1994) (17)
- Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis. (2015) (17)
- Pathogenetic and diagnostic aspects of dialysis-related amyloidosis. (1995) (17)
- CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury (2021) (17)
- Contrast-enhanced CT imaging in patients with chronic kidney disease (2016) (17)
- Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University (2018) (17)
- The role of PDGF-D in mesangioproliferative glomerulonephritis. (2007) (17)
- Electronic Alerts for Acute Kidney Injury. (2017) (16)
- Imaging Techniques in the Diagnosis of Dialysis‐Related Amyloidosis (2001) (16)
- Increased Cerebral Water Content in Hemodialysis Patients (2015) (16)
- PDGF-D and renal disease: yet another one of those growth factors? (2003) (16)
- Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients (2016) (16)
- Differential Expression of Mcp-1 and Its Receptor CCR2 in Glucose Primed Human Mesangial Cells (2002) (16)
- Amyloidosis and its relationship to different dialysers. (1994) (15)
- Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schönlein purpura. (1999) (15)
- Renal lipidosis in patients enrolled in a methadone substitution program. (2014) (15)
- Magnesium Concentration in Dialysate: Is Higher Better? (2018) (15)
- Comprar Comprehensive Clinical Nephrology, 4th Edition | Richard J. Johnson | 9780323058766 | Mosby (2010) (15)
- Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic (2020) (15)
- The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus. (2019) (15)
- Underestimated complications in thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome. (2004) (14)
- An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo. (2005) (14)
- Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study. (2021) (14)
- Dialysis-related amyloidosis and high-flux membranes. (1992) (14)
- Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis (2019) (14)
- Combined immunosuppression in high-risk patients with IgA nephropathy? (2010) (13)
- Uraemia disrupts the vascular niche in a 3D co-culture system of human mesenchymal stem cells and endothelial cells. (2012) (13)
- Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013 (2019) (13)
- Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all‐cause mortality† (2015) (13)
- Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis. (2004) (13)
- The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis. (2007) (13)
- Unclear fever 7 weeks after renal transplantation in a 56-year-old patient. (2006) (13)
- Therapeutic targets for prevention and regression of progressive fibrosing renal diseases. (2005) (13)
- The SDF-1/CXCR4 axis is a novel driver of vascular development of the glomerulus. (2009) (13)
- Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease. (2019) (13)
- The ERA-EDTA Database on Recurrent Glomerulonephritis following renal transplantation. (2014) (13)
- Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease (2020) (13)
- Epicardial adipose tissue in long-term hemodialysis patients: its association with vascular calcification and long-term development (2016) (12)
- Glomerular cells in the progression of human and experimental nephropathies. (1997) (12)
- Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration. (2001) (12)
- Scintigraphic methods to detect β2‐microglobulin associated amyloidosis (Aβ2‐microglobulin amyloidosis) (2001) (12)
- Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort. (2020) (12)
- [Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?]. (2007) (11)
- Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics (2008) (11)
- New Aspects of Kidney Fibrosis–From Mechanisms of Injury to Modulation of Disease (2022) (11)
- COVID-19 Prevalence and Mortality in Chronic Dialysis Patients. (2021) (11)
- Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit? (2009) (11)
- The nucleic acid binding protein YB-1-controlled expression of CXCL-1 modulates kidney damage in liver fibrosis. (2019) (11)
- Long‐term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients (2018) (11)
- Factor XII activation markers do not reflect FXII dependence of thrombin generation induced by polyvinylchloride (2013) (11)
- Clinical features of hemodialysis patients with intimal versus medial vascular calcifications. (2009) (11)
- Con: STOP immunosuppression in IgA nephropathy. (2016) (11)
- Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism. (2016) (11)
- Primary glomerulonephritis: A review of important recent discoveries (2013) (11)
- Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study (2018) (11)
- Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks (2011) (11)
- On the specificity of assays to detect circulating immunoglobulin A-fibronectin complexes: implications for the study of serologic phenomena in patients with immunoglobulin A nephropathy. (1994) (11)
- In vitro studies on hirudin elimination by haemofiltration: comparison of three high-flux membranes. (2002) (11)
- Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms (2013) (10)
- Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial (2021) (10)
- The urinary sediment beyond light microscopical examination. (2006) (10)
- Management of intraocular hypertension during hemodialysis by intravenous glucose administration. (2014) (10)
- Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease. (2021) (10)
- Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis). (2001) (10)
- Non-invasive molecular imaging of kidney diseases (2021) (10)
- A Functional Landscape of CKD Entities From Public Transcriptomic Data (2019) (10)
- Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis. (2021) (9)
- Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery (2015) (9)
- Antagonism of canonical Wnt/β-catenin signaling: taking RAS blockade to the next level? (2015) (9)
- Glomerular Remodelling: Novel Therapeutic Approaches Derived from the Apparently Chaotic Growth Factor Network (2002) (9)
- Hospitalization and mortality following non-attendance for hemodialysis according to dialysis day of the week: a European cohort study (2020) (9)
- Calcimimetics in CKD—results from recent clinical studies (2008) (9)
- Vitamin K and cardiovascular complications in CKD patients. (2021) (9)
- Cardiovascular disease in patients with chronic kidney disease (2020) (9)
- Glomerular disease: The Oxford classification—predicting progression of IgAN (2009) (9)
- Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy (2020) (9)
- In search of a better understanding of IgA nephropathy-associated hematuria. (2012) (9)
- The new SFB/TRR219 Research Centre. (2018) (9)
- Inverse correlation between vascular endothelial growth factor back-filtration and capillary filtration pressures (2018) (8)
- Cinacalcet, FGF23 and Cardiovascular Disease in Hemodialysis: The EVOLVE Trial (2015) (8)
- Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane? (1988) (8)
- Sucroferric oxyhydroxide for the treatment of hyperphosphatemia (2018) (8)
- Klotho Deficiency and the Cardiomyopathy of Advanced CKD. (2015) (8)
- Low adherence to CKD-specific dietary recommendations associates with impaired kidney function, dyslipidemia, and inflammation (2021) (8)
- IgA nephropathy: toward more specific diagnosis (and rescue of snails). (2018) (8)
- Goto-Kakizaki rat is protected from proteinuria after induction of anti-Thy1 nephritis. (2002) (8)
- Bone marrow transplantation rescues Alport mice. (2006) (8)
- Non-invasive evaluation of coronary heart disease in patients with chronic kidney disease using photoplethysmography (2019) (8)
- An update on herpes virus infections in graft recipients. (2003) (8)
- Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation (2010) (8)
- The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics (2021) (8)
- Calcification in arteriovenous fistula blood vessels may predict arteriovenous fistula failure: a 5-year follow-up study (2017) (8)
- Bacterial protease for the treatment of IgA nephropathy. (2008) (7)
- Littoral cell angioma of the spleen mimicking posttransplantation lymphoma in a 63-year-old renal transplant patient. (2008) (7)
- Monitoring transcellular fluid shifts during episodes of intradialytic hypotension using bioimpedance spectroscopy (2019) (7)
- Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS (2022) (7)
- CHAPTER 81 – Bone and Mineral Metabolism in Chronic Kidney Disease (2010) (7)
- Cytokines and Growth Factors (2008) (7)
- Immunosuppression in IgA nephropathy: how certain are we? (2016) (7)
- Mucosal corticosteroid therapy of IgA nephropathy. (2017) (7)
- Peripheral chemosensor function is blunted in moderate to severe chronic kidney disease. (2012) (7)
- Epidemiology, Pathophysiology, and Therapy of Calciphylaxis (2007) (7)
- Association of SGK 1 Gene polymorphisms with type 2 diabetes (2008) (7)
- The activated mesangial cell (1992) (7)
- Glomerulonephritis triggered by a chronically infected left ventricular assist device (2015) (7)
- Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review (2020) (7)
- Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease (2019) (7)
- YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy. (2018) (7)
- Cardiovascular complications of chronic kidney disease: pioneering studies. (2020) (7)
- Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. (2021) (7)
- Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice (2013) (6)
- Cold Shock Proteins Mediate GN with Mesangioproliferation. (2016) (6)
- PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy. (2007) (6)
- Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013 (2019) (6)
- Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function. (1990) (6)
- Left Ventricular Structure in Patients With Mild-to-Moderate CKD—a Magnetic Resonance Imaging Study (2018) (6)
- Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure (2022) (6)
- Cytokines and inflammation. (2012) (6)
- CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with Proteinuria (2018) (6)
- Speckle Tracking Echocardiography and All-Cause and Cardiovascular Mortality Risk in Chronic Kidney Disease Patients (2019) (6)
- Transplantation: An end to bone disease after renal transplantation? (2013) (6)
- Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy (2018) (6)
- Pilot study of non‐contrast‐enhanced MRI vs. ultrasound in renal transplant recipients with acquired cystic kidney disease: a prospective intra‐individual comparison (2013) (6)
- Time‐dependent lipid profile inversely associates with mortality in hemodialysis patients – independent of inflammation/malnutrition (2021) (5)
- Mortality in chronic kidney disease and mineral metabolism. (2011) (5)
- Prognostic assessment of IgA nephropathy: how much does histology add? (2016) (5)
- Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension. (2019) (5)
- Glomerular disease: Efficacy of corticosteroids in high-risk IgA nephropathy (2015) (5)
- Is mesangial cell proliferation required for extracellular matrix expansion in glomerular disease? (1994) (5)
- Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients. (2000) (5)
- Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes (2019) (5)
- Adult human kidney organoids originate from CD24+ cells and represent an advanced model for adult polycystic kidney disease (2022) (5)
- Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients (2021) (5)
- Usefulness of Bioimpedance Spectroscopy for Detection of Hypotensive Episode during Dialysis (2014) (5)
- Hyperuricemia and progression of chronic kidney disease: to treat or not to treat? (2021) (5)
- Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial (2022) (5)
- Cationic dextran induces mesangioproliferative nephritis in rats independent of glomerular IgA deposition. (1997) (4)
- Note from the Editorial Office (2008) (4)
- Influence of body position, food and beverage consumption on BIS measurements (2010) (4)
- CHAPTER 16 – Introduction to Glomerular Disease: Histologic Classification and Pathogenesis (2010) (4)
- Extracellular Actin Impairs Glomerular Capillary Repair in Experimental Mesangioproliferative Glomerulonephritis (2003) (4)
- Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients. (2018) (4)
- Bone pain with scintigraphy suggestive of widespread metastases--do not forget phosphate. (2002) (4)
- Minimal change nephrotic syndrome in a 74-year-old patient following parenteral administration of sheep cells. (1998) (4)
- Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression (2021) (4)
- Glomerular disease: Rituximab therapy for IgA nephropathy (2017) (4)
- Challenging the use of warfarin in patients on dialysis with atrial fibrillation (2015) (4)
- Beta 2-microglobulin kinetics during haemofiltration. (1988) (4)
- In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL. (2011) (4)
- [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria]. (2006) (4)
- Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury (Journal of Clinical Investigation (2009) 119, (1286-1297) DOI: 10.1172/JCI38399) (2009) (4)
- [What is certain in the treatment of glomerulonephritis?] (2018) (4)
- Antimalarials in IgA Nephropathy: Did Our Supportive Therapy Armamentarium Just Increase? (2019) (4)
- Ten-year advances in immunopathology of glomerulonephritis: translated into patients’ care or lost in translation? (2014) (4)
- The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021. (2021) (4)
- Clinical management of vascular and soft tissue calcifications in chronic kidney disease patients (2010) (3)
- Combining phosphate binder therapy with vitamin K2 inhibits vascular calcification in an experimental animal model of kidney failure. (2021) (3)
- Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation (2020) (3)
- Complications Related to Water Treatment, Substitution Fluids and Dialysate Composition (2000) (3)
- Clinical aspects of dialysis-related amyloidosis. (1995) (3)
- Cre recombinase toxicity in podocytes, a novel genetic model for FSGS in adolescent mice. (2019) (3)
- Mineral and bone disorder in chronic kidney disease: pioneering studies. (2020) (3)
- A challenge to the kidney community by a man-made crisis. (2022) (3)
- A new tool to predict the risk of progression in IgA nephropathy. (2019) (3)
- Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease. (2021) (3)
- Diagnostic aspects of beta 2-microglobulin amyloidosis. (1996) (3)
- Next-Generation Morphometry for pathomics-data mining in histopathology (2023) (3)
- Speckle-tracking echocardiography in comparison with ejection fraction for prediction of cardiovascular mortality in patients with end-stage renal disease (2021) (3)
- Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) Cohort (2022) (3)
- Chronic kidney disease: How effective and safe are antiplatelet agents in CKD? (2013) (3)
- Current kidney function parameters overestimate kidney tissue repair in reversible experimental kidney disease. (2022) (3)
- [Nomenclature for kidney function and kidney diseases - Improving assessment and prognosis through precision and comprehensibility]. (2022) (3)
- Survival on four compared with three times per week haemodialysis in high ultrafiltration patients: an observational study (2020) (3)
- P66 VITAMIN K2 SUPPLEMENTATION REDUCES THE ELEVATED INACTIVE FORM OF THE CALCIFICATION INHIBITOR MATRIX Gla PROTEIN IN HEMODIALYSIS PATIENTS (2010) (3)
- Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium. (2019) (3)
- Is mycophenolate mofetil an effective treatment for persistent proteinuria in patients with IgA nephropathy? (2006) (3)
- Moderator's view: will 'modern' urine proteomics replace 'old-fashioned' renal biopsy? (2015) (3)
- [Calciphylaxis. A call for interdisciplinary cooperation]. (2011) (3)
- Macrophage activation syndrome in a patient with pulmonary inflammatory myofibroblastic tumour (2012) (3)
- Soft tissue calcification in mice is governed by fetuin-A, pyrophosphate and magnesium (2019) (3)
- Coumarin use in dialysis patients with arterial fibrillation : yes , after individual risk stratification (2010) (2)
- Blood-dialyzer interactions: their role in long-term complications of hemodialysis. (1992) (2)
- Glomerular disease: Immunosuppressant-induced reduction of proteinuria in IgAN (2016) (2)
- Biochemical basis for transport processes in archinephric duct of the Atlantic hagfish (Myxine glutinosa) (1982) (2)
- The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathy. (2021) (2)
- Принципы ведения гломерулярных болезней (часть 2): итоги согласительной конференции Kidney disease: improving global outcomes (KDIGO) по спорным вопросам (2021) (2)
- Identification of central venous hemodialysis catheter-related infection by a semiquantitative culture method. (2007) (2)
- GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy (2021) (2)
- Editorial report 2010. (2011) (2)
- Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial (2023) (2)
- The longer the better: follow-up in seemingly 'benign' immunoglobulin A nephropathy. (2017) (2)
- Experimental pathology - 2 (2009) (2)
- A Focus Group Study of Self-Management in Patients With Glomerular Disease (2021) (2)
- Quantification of human urinary free secretory component, secretory and nonsecretory IgA by ELISA. (1989) (2)
- Diagnostic approaches to AB-amyloidosis. (1991) (2)
- Transplantation: basic science and immune-tolerance (2011) (2)
- A Core Outcome Set for Trials in Glomerular Disease (2021) (2)
- Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study (2020) (2)
- Models of IgA nephropathy (2010) (2)
- Evaluation of Electrocardiographic Parameters Predicting Cardiovascular Events in Patients with End-Stage Renal Disease before and after Transplantation (2019) (2)
- Mutant mice provide new insight into the role of (mis-)glycation in IgA nephropathy and other glomerular diseases. (2007) (2)
- Fundamentals and applications of immunoadsorption (2010) (2)
- Knee-to-knee Bioimpedance Measurements to Monitor Changes in Extracellular Fluid in Haemodynamic-unstable Patients During Dialysis (2019) (2)
- CKD pathophysiology and complications (2013) (2)
- TO013PROTEINURIA REDUCTION IN IGA NEPHROPATHY BY NEFECON, A TARGETED‑RELEASE FORMULATION OF BUDESONIDE - RESULTS FROM THE NEFIGAN TRIAL (2017) (2)
- Heart failure in advanced chronic kidney disease: treatment rationale (2021) (2)
- Kidney International and the COVID-19 infection (2020) (2)
- [Perspectives 2025 - Positions of the German Society of Internal Medicine]. (2019) (1)
- Size heterogeneity of amyloid fibril proteins of beta 2-microglobulin origin in hemodialysis and disease-specific antibodies. (1995) (1)
- Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism (2022) (1)
- Changes to the Editorial Board and the launch of NDT plus (2007) (1)
- Beta 2-microglobulin-derived amyloidosis: clinical use of scintigraphy and insights into its pathogenesis. (1993) (1)
- Assessing prognosis in IgA nephropathy. (2022) (1)
- ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap (2016) (1)
- Impact of sucroferric oxyhydroxide on the oral and intestinal microbiome in hemodialysis patients (2022) (1)
- Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG). (2023) (1)
- Does hemodialysis induce muscular release of myoglobin? (1988) (1)
- MP365SUCROFERRIC OXYHYDROXIDE DOES NOT IMPACT THE IPTH-LOWERING EFFECTS OF ORAL VDRAS OR CINACALCET: A POST HOC ANALYSIS OF A PHASE 3 STUDY (2016) (1)
- Improving Global Outcomes ( KDIGO ) Controversies Management and treatment of glomerular diseases ( part 1 ) : conclusions from a Kidney Disease : Conference (2019) (1)
- TO032CONSEQUENCES AND FATE OF INTRARENAL CRYSTALS IN ADENINE NEPHROPATHY (2016) (1)
- Precision medicine in immunoglobulin A nephropathy: still a journey ahead. (2021) (1)
- Authors' Reply: Advanced Tertiary Lymphoid Tissues in Protocol Biopsies in Kidney Transplant Recipients: Addressing Additional Methods To Detect Intragraft B Cells. (2022) (1)
- International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology. (2023) (1)
- The five most cited NDT papers from 2005 to 2009. (2010) (1)
- Pro-Angiogenic and Antimesangioproliferative Effects (2012) (1)
- AB-Amyloidosis and Monokines (1991) (1)
- Atrial fibrillation and chronic kidney disease. (2012) (1)
- Reduction of endothelial glycocalyx on peritubular capillaries in chronic kidney disease. (2022) (1)
- Mechanisms of Progression in Renal Disease (1999) (1)
- Novel insights into osteogenesis and matrix remodelling associated with calci fi c uraemic arteriolopathy (2013) (1)
- AB0154 Notch3 is upregulated in lupus nephritis and its deficiency accelerates lupus progression (2018) (1)
- IgA nephropathy: a perspective for 2021 (2021) (1)
- The management of membranous nephropathy - an update. (2021) (1)
- Several β2-Microglobulin Fragments Identified in an Amyloidoma in a Patient with Long-Term Hemodialysis (1991) (1)
- FP357 THE CLINICAL EVALUATION OF LOW DOSE HEPARIN IN HEMODIALYSIS: A PROSPECTIVE STUDY USING THE HEPARIN-COATED AN69 ST MEMBRANE (2007) (1)
- Epidemiology - cardiovascular outcomes (2013) (1)
- No clinically relevant changes in Vitamin D Concentrations with PA21, a Novel Iron-Based Phosphate Binder, Over 52 Weeks (2014) (1)
- MO025NON-INVASIVE MOLECULAR IMAGING OF KIDNEY FIBROSIS (2016) (1)
- YB-1 IS THE CRUCIAL MEDIATOR OF ANTIFIBROTIC IFN-γ EFFECTS (2005) (1)
- SP100KERATINS AS NOVEL MARKERS OF RENAL EPITHELIAL CELL INJURY (2015) (1)
- The immunopathogenesis of IgA-nephropathy. (1998) (1)
- Effects of Perfusion Pressures on Podocyte Loss in the Isolated Perfused Mouse Kidney. (2021) (1)
- MP381CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO TREATMENT WITH SUCROFERRIC OXYHYDROXIDE: A POST HOC ANALYSIS OF A PHASE 3 STUDY (2016) (1)
- How I Treat IgA Nephropathy. (2022) (1)
- Collagen-specific molecular imaging of renal fibrosis (2020) (1)
- [IgA nephropathy: frequent, but rarely diagnosed]. (2003) (1)
- Potential Risks of Stem Cell Therapies (2011) (1)
- [IgA-nephropathy: the most common type of glomerulonephritis]. (2003) (1)
- Cytokines in the progression of renal disease. (1993) (1)
- CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC (2011) (1)
- Beta-2-microglobulin and dialysis-related amyloidosis. Recent developments. (1989) (1)
- Therapy of patients with IgA-nephropathy: a critical appraisal. (2000) (1)
- Rationale and design of XARENO: XA inhibition in RENal patients with non-valvular atrial fibrillation Observational registry. (2021) (1)
- SP048UNRAVELING THE MECHANISM OF ACTION OF GLUCOCORTICOIDS IN GLOMERULONEPHRITIS (2015) (1)
- Arteriosclerotic aorta calcifications characterized by TEM and electron crystallography (2006) (1)
- Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials : A Meta-Analysis of Treatment Effects of Randomized Controlled Trials (2019) (0)
- P0794A REAL-WORLD OBSERVATIONAL STUDY OF ETELCALCETIDE USE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN EUROPE (2020) (0)
- Differential prognostic utility of adiposity measures in chronic kidney disease. (2023) (0)
- Future optimization of hemodialysis procedure by application of electrical impedance spectroscopy (2020) (0)
- Diagnosis and Treatment of Patients With FSGS/SRNS: A Delphi Survey (2022) (0)
- [Long-term management of dialysis patients. I. Hypertension and anemia]. (1999) (0)
- and matrix production in vivo (1997) (0)
- MP281CONTRAST-ENHANCED CT IMAGING IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2016) (0)
- [Heart & kidney-an unholy alliance]. (2020) (0)
- MO056: Alteration of Glycocalyx on Endothelium of Peritubular Capillaries in CKD (2022) (0)
- Editorial / Publisher’s Note (2002) (0)
- CD8 T cells specific for a glomerular antigen induce renal inflammation in a CD4 help dependent fashion and may cause progressing Glomerulonephritis (2008) (0)
- FP349TRENDS OF RENAL DISEASES IN GERMANY: A REVIEW OF A REGIONAL RENAL BIOPSY DATABASE FROM 1990-2013 (2015) (0)
- [Magnesium: a kardio-renal viewpoint]. (2016) (0)
- TESTING the effects of corticosteroids in patients with IgA nephropathy. (2022) (0)
- OUTCOMES OF COVID-2019 IN RENAL TRANSPLANT RECIPIENTS VERSUS CHRONIC HEMODIALYSIS PATIENTS: ANALYSIS OF A REGIONAL COHORT (2020) (0)
- Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD (2023) (0)
- CKD PATHOPHYSIOLOGY AND CLINICAL STUDIES (2014) (0)
- Publisher Correction: Non-invasive molecular imaging of kidney diseases (2021) (0)
- [Creatinine increase as accidental finding]. (2006) (0)
- Comment Nephrology Dialysis Transplantation Cytokines in the progression of renal disease (2005) (0)
- [Long-term management of dialysis patients. II. Beta 2-microglobulin associated amyloidosis and acquired cystic kidney disease]. (1999) (0)
- SP329VITAMIN K ELIMINATES UREMIC POSTTRANSLATIONAL MODIFICATIONS OF THE GAMMA-GLUTAMYL CARBOXYLASE (2016) (0)
- Immunadsorption bei therapierefraktärer Polymyositis (2011) (0)
- Milestones in nephrology and welcoming the future: the 61st anniversary of the International Society of Nephrology. (2021) (0)
- 808-P: Association between Analogue Compared with Human Insulin and the Outcomes of Mortality, Hospitalization, MACE, and Hypoglycemia in Hemodialysis Patients with Type 2 Diabetes: The ARO Research Initiative (2022) (0)
- The importance of residual renal function for patients on dialysis (2005) (0)
- MO011SNF472 - A POTENTIAL NOVEL CALCIFICATION INHIBITOR IN CKD-MBD (2016) (0)
- NON-INVASIVE IN VIVO DETECTION OF AB-AMYLOIDOSIS USING ITS RADIOLABELLED PRECURSOR PROTEIN* (1991) (0)
- Survival with low- and high-flux dialysis (2020) (0)
- Cardiovascular complications - 2 (2009) (0)
- Validation of a Prospective Urinalysis-Based Prediction Model for the Outcome of COVID-19 Disease: A Multicenter Cohort Study (2020) (0)
- THE ULTRASTRUCTURE OF ARTERIOSCLEROSIS IN PATIENTS WITH ENDSTAGE RENAL DISEASE (2006) (0)
- [Science as a cornerstone of medical education and training]. (2019) (0)
- Dialysis / Mineral bone disease 1 (2011) (0)
- [Internal Medicine - from Guidelines to "Choosing Wisely"]. (2017) (0)
- Acute kidney injury - Human studies (2011) (0)
- The authors reply. (2019) (0)
- MP173 THE GERMAN CYLCIPHYLAXIS REGISTRY (2013) (0)
- Pathophysiology and clinical studies in CKD 5D (2011) (0)
- Y-box-binding protein (YB-1) in murine models of hepatic and renal fibrosis (2015) (0)
- Poster Session 4: Miscellaneous (2009) (0)
- Recommended fluid intake should be tailored to the individual. (2010) (0)
- Quantitative brain water content maps. (2015) (0)
- Platelet-derived growth factor (PDGF) (2008) (0)
- SP096COMMON PATTERNS OF GLOMERULAR EPITHELIAL CELLS IN HUMAN SECONDARY FSGS LESIONS (2015) (0)
- Magnesium Improves Cardiac Function in Experimental Uremia by Altering Cardiac Elastin Protein Content (2023) (0)
- MO066: The Role of Platelet-Derived Growth Factor in Focal Segmental Glomerulosclerosis (2022) (0)
- TO006VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) BACKFILTRATION IN THE RENAL GLOMERULUS (2017) (0)
- [Incidental finding: elevated serum creatinine]. (2010) (0)
- IgA nephropathy - New insights into pathogenesis and therapy (2011) (0)
- Cardiovascular disease in patients with chronic kidney disease (2021) (0)
- KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study. (2023) (0)
- PDGF-D: a novel mediator of mesangioproliferative glomerulonephritis (2004) (0)
- Release of heat shock protein 60 is an endogenous enhancer of nephrotoxic nephritis (2003) (0)
- Subject Index, Vol. 55, 1990 (1990) (0)
- Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides ∗ (2009) (0)
- Erratum to: Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation. (2020) (0)
- Vitamin K in vascular health - more than just a role in coagulation (2008) (0)
- Change in Albuminuria and GFR Slope as Joint Surrogate Endpoints for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD. (2023) (0)
- Heart and bone in CKD - A (2013) (0)
- New insights into the pathogenesis of IgA nephropathy (2014) (0)
- Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial. (2022) (0)
- FP088HETEROGENEITY AND CLINICAL RELEVANCE OF TERTIARY LYMPHOID TISSUES IN MURINE AND HUMAN KIDNEYS (2018) (0)
- Under embargo until June 2 , 2014 , 09 : 30 local time ! LATE BREAKING CLINICAL TRIALS Hyperparathyroidism : Medical or Surgical Treatment ? (2014) (0)
- ADVANCED TERTIARY LYMPHOID TISSUES IN PROTOCOL BIOPSIES PREDICT PROGRESSIVE GRAFT DYSFUNCTION IN KIDNEY TRANSPLANT RECIPIENTS (2020) (0)
- [Renovascular hypertension--diagnosis and therapy]. (2005) (0)
- CKD PROGRESSION MO025 NON-INVASIVE MOLECULAR IMAGING OF KIDNEY FIBROSIS (2016) (0)
- SP321DISSECTING THE MOLECULAR DIFFERENCES BETWEEN CHRONIC KIDNEY DISEASE SUBTYPES FROM TRANSCRIPTOMICS DATA (2019) (0)
- in Experimental Mesangioproliferative Glomerulonephritis (1998) (0)
- Klotho: An Elixir of Youth for the Vasculature? (2011) (0)
- Genetic diseases and molecular genetics (2013) (0)
- Parathyroid hormone oxidation in chronic kidney disease: clinical relevance? (2021) (0)
- MO331LINEAGE TRACING OF REGENERATING PROXIMAL TUBULE CELLS (STC) BY SINGLE CELL PROFILING IN ACUTE KIDNEY INJURY (2021) (0)
- DISEASE OF THE MONTH IgA Nephropathy : Recent Developments (2000) (0)
- Subject Index Vol. 92, 2002 (2002) (0)
- DNA binding protein YB-1 is a part of the neutrophil extracellular trap mediation of kidney damage and cross-organ effects. (2023) (0)
- Decoding myofibroblast origins in human kidney fibrosis (2020) (0)
- Acknowledgement to the Reviewers (1998) (0)
- MP344THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY (2016) (0)
- Salt wars. (2008) (0)
- Author Index to Abstracts (2002) (0)
- High-fat diet-induced obesity causes an inflammatory microenvironment in the kidneys of aging Long-Evans rats (2019) (0)
- In order to improve CKD – MBD outcomes , in 2003 , the National Kidney Foundation launched the Kidney Dialysis (2012) (0)
- FC060THE ASSOCIATION BETWEEN FOUR TIMES A WEEK COMPARED TO THREE TIMES A WEEK HAEMODIALYSIS AND SURVIVAL, HOSPITALISATION AND VASCULAR ACCESS COMPLICATIONS IN EUROPEAN IN-CENTRE PATIENTS (2019) (0)
- Cell signalling / Growth factors (2011) (0)
- Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study. (2022) (0)
- Experimental models of CKD (2013) (0)
- CONSTITUTIVE ACTIVATION OF PDGFR-beta IN RENAL MESENCHYMAL CELLS DRIVES RENAL FIBROSIS (2016) (0)
- SP600IMPACT OF VASCULAR ACCESS CALCIFICATION ON ARTERIO-VENOUS FISTULA FAILURE: A FIVE-YEAR PROSPECTIVE STUDY (2015) (0)
- [Therapy and prophylaxis of renal failure]. (2003) (0)
- Results Effects of Selective COX-2 Inhibitors on Mesangiolytic Injury and Albuminuria (2002) (0)
- [Strengthen Internal Medicine Generalists]. (2020) (0)
- IgA-Nephropathie (2008) (0)
- Immunoadsorption in therapy-resistant polymyositis (2011) (0)
- Underestimated Risk Indicator of Thromboembolic Events Platelet Hyperaggregability is Highly Prevalent in Patients With Chronic Kidney Disease : An (2013) (0)
- GAS6 PROTEIN AND ITS ROLE IN VASCULAR CALCIFICATION (2013) (0)
- Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis ( NIH FSGS ) clinical trial on the treatment of steroid-resistant FSGS (2013) (0)
- In-Depth Review Management of hyperphosphataemia in chronic kidney disease — challenges and solutions (2013) (0)
- New Diagnostic and Therapeutic Aspects in IgA Nephropathy (2008) (0)
- Low -turnover (adynamic) bone disease in CKD patients (2010) (0)
- How to write and publish a scientific paper (2012) (0)
- cell injury Keratins are novel markers of renal epithelial (2016) (0)
- Models for acute and chronic kidney diseases (2010) (0)
- Ultrasonographic fata morgana. (2003) (0)
- Contents Vol. 91, 2002 (2002) (0)
- FP631EFFECTS OF SODIUM THIOSULFATE ON CALCIFICATION OF ILIAC ARTERIES IN HEMODIALYSIS PATIENTS- A INTERVENTIONAL DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED STUDY (2019) (0)
- FC 079HIGH SERUM PHOSPHATE, A NOVEL POTENTIAL RISK FACTOR FOR BONE FRAGILITY FRACTURES IN THE COSMOS STUDY (2021) (0)
- Pathologieklassifikation der Immunglobulin-A-Nephropathie (2011) (0)
- Contents Vol. 92, 2002 (2002) (0)
- Phosphatbinder@@@Phosphate binders (2017) (0)
- [Treatment of IgA nephropathies: a critical viewpoint]. (2000) (0)
- Regression of Glomerulosclerosis: Fact or Myth? (2005) (0)
- Haplotype analysis of rs9275224, rs2856717, rs9275424, and rs9275596 at the HLA-DQB1/DRB1 locus. (2012) (0)
- P1394ASSOCIATION BETWEEN PARATHYROID HORMONE AND MORTALITY IN HAEMODIALYSIS: THE DIABETES MAKES THE DIFFERENCE (2020) (0)
- [Retarding progression of chronic kidney disease]. (2023) (0)
- Contents Vol. 118, 2011 (2011) (0)
- Supplementary Material for: Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients (2016) (0)
- [Screening: Let's Seize the Opportunity for Early Detection of Diseases]. (2018) (0)
- Collagen expression in renal fibrosis (2021) (0)
- MO185: Post-Translational Carbamylation of Sortilin is Associated with Cardiovascular Calcification in Chronic Kidney Disease (2022) (0)
- Bacterial and Sterile Inflammation In Vivo YB-1 Is an Early and Central Mediator of (2013) (0)
- International Physicians Delphi Survey: Managing Patients With IgA Nephropathy (2022) (0)
- [Nephrology 2005/2006. Recent clinical studies and developments in science]. (2006) (0)
- CASE REPORT Henoch-Schönlein Purpura Complicated by Cardiac Involvement: Case Report and Review of the Literature (2009) (0)
- Bone disease - 2 (2009) (0)
- [Nephrology -- familiar knowledge in the light of new discoveries in molecular and cell biology]. (2005) (0)
- Author Index/Subject Index Proceedings (2002) (0)
- Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study (2022) (0)
- Molecular Biology/Cell Biology/Human Genetics/Anatomy/ Embryology (2008) (0)
- Looking back and moving forward. (2017) (0)
- [Readers' letters concerning F, Keller et al: "Financial incentives and dialysis"]. (2008) (0)
- MO326CORTICOSTEROIDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REPORTED ADVERSE EVENTS IN RANDOMISED CONTROLLED TRIALS (2021) (0)
- Highlights of the 2015 ERA-EDTA Congress--glomerular diseases. (2016) (0)
- SP277CONSTITUTIVE ACTIVATION OF PDGFR-β IN RENAL MESENCHYMAL CELLS DRIVES RENAL FIBROSIS (2016) (0)
- A Hypercaloric Diet Induces Early Podocyte Damage in Aged, Non-Diabetic Rats. (2021) (0)
- Imaging of dialysis-related amyloid (AB-amyloid) deposits with radiolabelled microglobulin (2001) (0)
- Opponent's comments. (2016) (0)
- Management and treatment of glomerular diseases ( part 2 ) : conclusions from a Kidney Disease : Conference (2019) (0)
- Author Correction: Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits (2023) (0)
- Contents Vol. 93, 2003 (2003) (0)
- Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey (2022) (0)
- The Role of Platelet-Derived Growth Factor in Focal Segmental Glomerulosclerosis (2022) (0)
- Ten-year advances in immunopathology of glomerulonephritis: translated into patients’ care or lost in translation? (2014) (0)
- MP092EXPRESSION OF KERATIN 17 IN RENAL INJURY INDICATES TUBULAR STRESS AND DEDIFFERENTIATION (2016) (0)
- Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis (2019) (0)
- Quantitative Angiography as a Diagnostic Tool for Objective Control of Rheopheretic Treatment in Age Related Macular Degeneration (AMD) (2006) (0)
- Comparative analysis of C5aR and C5L2 receptor deficiency in liver and kidney fibrosis (2015) (0)
- PowerPoint Slides for: Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients (2016) (0)
- Heterogeneity and clinical relevance of tertiary lymphoid tissues in murine and human kidney (2018) (0)
- Bone and mineral diseases - 1 (2012) (0)
- Subject Index Vol. 91, 2002 (2002) (0)
- Contrast-enhanced CT imaging in patients with chronic kidney disease (2016) (0)
- Contents, Vol. 55, 1990 (1990) (0)
- MO442ACUTE ADVERSE EFFECTS OF LOW POTASSIUM ON HEART AND KIDNEY* (2021) (0)
- Central blood pressure: nice to know but not yet ready for routine practice. (2023) (0)
- Macrophage Migration Inhibitory Factor Limits Renal In fl ammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jürgen Floege?
Jürgen Floege is affiliated with the following schools: